{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:39:31Z","timestamp":1786981171480,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Key Technology Research and Development Program of China","award":["2015BAD11B00"],"award-info":[{"award-number":["2015BAD11B00"]}]},{"name":"the National Key Research and Development Program of China","award":["2018YFD0500302"],"award-info":[{"award-number":["2018YFD0500302"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31872516"],"award-info":[{"award-number":["31872516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10753-019-00994-3","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T02:16:17Z","timestamp":1554171377000},"page":"1336-1349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Tizoxanide Inhibits Inflammation in LPS-Activated RAW264.7 Macrophages via the Suppression of NF-\u03baB and MAPK Activation"],"prefix":"10.1007","volume":"42","author":[{"given":"Jiaoqin","family":"Shou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhen","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiqun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"994_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev-pharmtox-011613-140002","volume":"54","author":"MD Howard","year":"2014","unstructured":"Howard, M.D., E.D. Hood, B. Zern, V.V. Shuvaev, T. Grosser, and V.R. Muzykantov. 2014. Nanocarriers for vascular delivery of anti-inflammatory agents. Annual Review of Pharmacology and Toxicology 54: 205\u2013226.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"994_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","volume":"40","author":"A Roy","year":"2016","unstructured":"Roy, A., M. Srivastava, U. Saqib, D. Liu, S.M. Faisal, S. Sugathan, S. Bishnoi, and M.S. Baig. 2016. Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)\u2013mediated signaling pathways. International Immunopharmacology 40: 79\u201389.","journal-title":"International Immunopharmacology"},{"key":"994_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00011-015-0863-4","volume":"64","author":"P Xiang","year":"2015","unstructured":"Xiang, P., T. Chen, Y. Mou, H. Wu, P. Xie, G. Lu, X. Gong, Q. Hu, Y. Zhang, and H. Ji. 2015. NZ suppresses TLR4\/NF-\u03baB signalings and NLRP3 inflammasome activation in LPS-induced RAW264.7 macrophages. Inflammation Research 64: 799\u2013808.","journal-title":"Inflammation Research"},{"key":"994_CR4","doi-asserted-by":"publisher","first-page":"263543","DOI":"10.1155\/2015\/263543","volume":"2015","author":"Y Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez, Y., D. Torres-Mendoza, G.E. Jones, and P.L. Fernandez. 2015. Marine diterpenoids as potential anti-inflammatory agents. Mediators of Inflammation 2015: 263543.","journal-title":"Mediators of Inflammation"},{"issue":"3","key":"994_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10753-018-0737-3","volume":"41","author":"N Liang","year":"2018","unstructured":"Liang, N., Y. Sang, W. Liu, W. Yu, and X. Wang. 2018. Anti-inflammatory effects of gingerol on lipopolysaccharide-stimulated RAW 264.7 cells by inhibiting NF-\u03baB signaling pathway. Inflammation 41 (3): 835\u2013845.","journal-title":"Inflammation"},{"key":"994_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/femsre\/fuv026","volume":"39","author":"F Putker","year":"2015","unstructured":"Putker, F., M.P. Bos, and J. Tommassen. 2015. Transport of lipopolysaccharide to the gram-negative bacterial cell surface. FEMS Microbiology Reviews 39: 985\u20131002.","journal-title":"FEMS Microbiology Reviews"},{"key":"994_CR7","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.bcp.2010.06.019","volume":"80","author":"M Piazza","year":"2010","unstructured":"Piazza, M., V. Calabrese, C. Baruffa, T. Gioannini, J. Weiss, and F. Peri. 2010. The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding. Biochemical Pharmacology 80: 2050\u20132056.","journal-title":"Biochemical Pharmacology"},{"key":"994_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2016.10.005","volume":"44","author":"CV Rosadini","year":"2017","unstructured":"Rosadini, C.V., and J.C. Kagan. 2017. Early innate immune responses to bacterial LPS. Current Opinion in Immunology 44: 14\u201319.","journal-title":"Current Opinion in Immunology"},{"key":"994_CR9","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A., X. He, I. Smirnova, M.Y. Liu, C. Van Huffel, et al. 1998. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085\u20132088.","journal-title":"Science"},{"key":"994_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.molcel.2014.03.012","volume":"54","author":"Y Tan","year":"2014","unstructured":"Tan, Y., and J.C. Kagan. 2014. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Molecular Cell 54: 212\u2013223.","journal-title":"Molecular Cell"},{"key":"994_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1349-7006.2008.00763.x","volume":"99","author":"S Maeda","year":"2008","unstructured":"Maeda, S., and M. Omata. 2008. Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Science 99: 836\u2013842.","journal-title":"Cancer Science"},{"issue":"1","key":"994_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-016-0447-7","volume":"40","author":"JL Lai","year":"2017","unstructured":"Lai, J.L., Y.H. Liu, C. Liu, M.P. Qi, R.N. Liu, X.F. Zhu, Q.G. Zhou, Y.Y. Chen, A.Z. Guo, and C.M. Hu. 2017. Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-kB and MAPK signaling pathways. Inflammation 40 (1): 1\u201312.","journal-title":"Inflammation"},{"key":"994_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","volume":"6","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal, B.B. 2004. Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203\u2013208.","journal-title":"Cancer Cell"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.intimp.2011.12.009","volume":"12","author":"A Olivera","year":"2012","unstructured":"Olivera, A., T.W. Moore, F. Hu, A.P. Brown, A. Sun, D.C. Liotta, J.P. Snyder, Y. Yoon, H. Shim, A.I. Marcus, A.H. Miller, and T.W.W. Pace. 2012. Inhibition of the NF-\u03baB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. International Immunopharmacology 12: 368\u2013377.","journal-title":"International Immunopharmacology"},{"key":"994_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molbiopara.2013.12.002","volume":"193","author":"VS Somvanshi","year":"2014","unstructured":"Somvanshi, V.S., B.L. Ellis, Y. Hu, and R.V. Aroian. 2014. Nitazoxanide: nematicidal mode of action and drug combination studies. Molecular and Biochemical Parasitology 193: 1\u20138.","journal-title":"Molecular and Biochemical Parasitology"},{"key":"994_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tube.2016.03.002","volume":"98","author":"EP Harausz","year":"2016","unstructured":"Harausz, E.P., K.A. Chervenak, C.E. Good, M.R. Jacobs, R.S. Wallis, M. Sanchez-Felix, W.H. Boom, and TB Research Unit (TBRU) at Case Western Reserve University. 2016. Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture. Tuberculosis (Edinburgh, Scotland) 98: 92\u201396.","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"994_CR17","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1021\/jm200153p","volume":"54","author":"AV Stachulski","year":"2011","unstructured":"Stachulski, A.V., C. Pidathala, E.C. Row, R. Sharma, N.G. Berry, M. Iqbal, J. Bentley, S.A. Allman, G. Edwards, A. Helm, J. Hellier, B.E. Korba, J.E. Semple, and J.F. Rossignol. 2011. Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication. Journal of Medicinal Chemistry 54: 4119\u20134132.","journal-title":"Journal of Medicinal Chemistry"},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","volume":"40","author":"LM Fox","year":"2005","unstructured":"Fox, L.M., and L.D. Saravolatz. 2005. Nitazoxanide: a new thiazolide antiparasitic agent. Clinical Infectious Diseases 40: 1173\u20131180.","journal-title":"Clinical Infectious Diseases"},{"key":"994_CR19","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/AAC.00901-09","volume":"54","author":"F Tchouaffi-Nana","year":"2010","unstructured":"Tchouaffi-Nana, F., T.E. Ballard, C.H. Cary, T.L. Macdonald, C.D. Sifri, and P.S. Hoffman. 2010. Nitazoxanide inhibits biofilm formation by staphylococcus epidermidis by blocking accumulation on surfaces. Antimicrobial Agents and Chemotherapy 54: 2767\u20132774.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"994_CR20","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1128\/AAC.40.10.2266","volume":"40","author":"L Dubreuil","year":"1996","unstructured":"Dubreuil, L., I. Houcke, Y. Mouton, and J.F. Rossignol. 1996. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrobial Agents and Chemotherapy 40: 2266\u20132270.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"994_CR21","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1128\/JVI.01213-13","volume":"87","author":"S Frazia La","year":"2013","unstructured":"La Frazia, S., A. Ciucci, F. Arnoldi, M. Coira, P. Gianferretti, M. Angelini, et al. 2013. Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation. Journal of Virology 87: 11096\u201311106.","journal-title":"Journal of Virology"},{"key":"994_CR22","doi-asserted-by":"publisher","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","volume":"284","author":"JF Rossignol","year":"2009","unstructured":"Rossignol, J.F., S. La Frazia, L. Chiappa, A. Ciucci, and M.G. Santoro. 2009. Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level. The Journal of Biological Chemistry 284: 29798\u201329808.","journal-title":"The Journal of Biological Chemistry"},{"key":"994_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/AAC.03947-14","volume":"59","author":"G Belardo","year":"2015","unstructured":"Belardo, G., O. Cenciarelli, S. La Frazia, J.F. Rossignol, and M.G. Santoro. 2015. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro. Antimicrobial Agents and Chemotherapy 59: 1061\u20131069.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"994_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","volume":"110","author":"JF Rossignol","year":"2014","unstructured":"Rossignol, J.F. 2014. Review: Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Research 110: 94\u2013103.","journal-title":"Antiviral Research"},{"key":"994_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5414\/CPP40213","volume":"40","author":"A Stockis","year":"2002","unstructured":"Stockis, A., A.M. Aleemon, S. De Bruyn, and C. Gengler. 2002. NTZ pharmacokinetics and tolerability in man using single ascending oral doses. International Journal of Clinical Pharmacology and Therapeutics 40: 213\u2013220.","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"994_CR26","doi-asserted-by":"publisher","first-page":"e1002691","DOI":"10.1371\/journal.ppat.1002691","volume":"8","author":"KK Lam","year":"2012","unstructured":"Lam, K.K., X. Zheng, R. Forestieri, A.D. Balgi, M. Nodwell, S. Vollett, et al. 2012. Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. PLoS Pathogens 8: e1002691.","journal-title":"PLoS Pathogens"},{"key":"994_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Analytical Biochemistry 126: 131\u2013138.","journal-title":"Analytical Biochemistry"},{"key":"994_CR28","first-page":"244","volume":"4","author":"GL Mazzone","year":"2010","unstructured":"Mazzone, G.L., I. Rigato, and C. Tiribelli. 2010. Unconjugated bilirubin modulates nitric oxide production via iNOS regulation. Bioscience Trends 4: 244\u2013248.","journal-title":"Bioscience Trends"},{"key":"994_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.intimp.2015.01.011","volume":"25","author":"T Chen","year":"2015","unstructured":"Chen, T., Y. Mou, J. Tan, L. Wei, Y. Qiao, T. Wei, P. Xiang, S. Peng, Y. Zhang, Z. Huang, and H. Ji. 2015. The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice. International Immunopharmacology 25: 55\u201364.","journal-title":"International Immunopharmacology"},{"key":"994_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783\u2013801.","journal-title":"Cell"},{"key":"994_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn, T.A., A. Chawla, and J.W. Pollard. 2013. Macrophage biology in development, homeostasis and disease. Nature 496: 445\u2013455.","journal-title":"Nature"},{"key":"994_CR32","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1084\/jem.20140654","volume":"212","author":"MS Baig","year":"2015","unstructured":"Baig, M.S., S.V. Zaichick, M. Mao, A.L. de Abreu, F.R. Bakhshi, P.C. Hart, U. Saqib, J. Deng, S. Chatterjee, M.L. Block, S.M. Vogel, A.B. Malik, M.E.L. Consolaro, J.W. Christman, R.D. Minshall, B.N. Gantner, and M.G. Bonini. 2015. NOS1-derived nitric oxide promotes NF-\u03baB transcriptional activity through inhibition of suppressor of cytokine signaling-1. The Journal of Experimental Medicine 212: 1725\u20131738.","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"994_CR33","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1128\/AAC.50.3.1112-1117.2006","volume":"50","author":"GA Pankuch","year":"2006","unstructured":"Pankuch, G.A., and P.C. Appelbaum. 2006. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species. Antimicrobial Agents and Chemotherapy 50 (3): 1112\u20131117.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"994_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1034\/j.1600-6143.2001.10404.x","volume":"1","author":"R Buelow","year":"2001","unstructured":"Buelow, R., S.G. Tullius, and H.D. Volk. 2001. Protection of grafts by hemoxygenase-1 and its toxic product carbon monoxide. American Journal of Transplantation 1: 313\u2013315.","journal-title":"American Journal of Transplantation"},{"key":"994_CR35","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.bmcl.2018.04.021","volume":"28","author":"ZY Wei","year":"2018","unstructured":"Wei, Z.Y., K.Q. Chi, K.S. Wang, J. Wu, L.P. Liu, and H.R. Piao. 2018. Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters 28: 1797\u20131803.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"3","key":"994_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1538\/expanim.17-0121","volume":"67","author":"B Jin","year":"2018","unstructured":"Jin, B., and H. Jin. 2018. Oxymatrine attenuates lipopolysaccharide-induced acute lung injury by activating the epithelial sodium channel and suppressing the JNK signaling pathway. Experimental Animals 67 (3): 337\u2013347.","journal-title":"Experimental Animals"},{"key":"994_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.intimp.2016.12.009","volume":"43","author":"TB Tumer","year":"2017","unstructured":"Tumer, T.B., F.C. Onder, H. Ipek, T. Gungor, S. Savranoglu, et al. 2017. Biological evaluation and molecular docking studies of nitro benzamide derivatives with respect to in vitro anti-inflammatory activity. International Immunopharmacology 43: 129\u2013139.","journal-title":"International Immunopharmacology"},{"key":"994_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.antiviral.2017.10.002","volume":"147","author":"D Tilmanis","year":"2017","unstructured":"Tilmanis, D., C. van Baalen, D.Y. Oh, J.F. Rossignol, and A.C. Hurt. 2017. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide. Antiviral Research 147: 142\u2013148.","journal-title":"Antiviral Research"},{"key":"994_CR39","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1182\/blood-2008-07-019307","volume":"113","author":"BA Beutler","year":"2009","unstructured":"Beutler, B.A. 2009. TLRs and innate immunity. Blood 113: 1399\u20131407.","journal-title":"Blood"},{"key":"994_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.intimp.2015.05.044","volume":"28","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Y. Cui, F. Cao, Y. Qin, W. Li, and J. Zhang. 2015. Ganglioside GD1a suppresses LPS-induced pro-inflammatory cytokines in RAW264.7 macrophages by reducing MAPKs and NF-kappaB signaling pathways through TLR4. International Immunopharmacology 28: 136\u2013145.","journal-title":"International Immunopharmacology"},{"key":"994_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.taap.2014.10.002","volume":"281","author":"XF Wu","year":"2014","unstructured":"Wu, X.F., Z.J. Ouyang, L.L. Feng, G. Chen, W.J. Guo, Y. Shen, X.D. Wu, Y. Sun, and Q. Xu. 2014. Suppression of NF-\u03baB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone. Toxicology and Applied Pharmacology 281: 146\u2013156.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"994_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.intimp.2012.03.002","volume":"13","author":"SK Hong","year":"2012","unstructured":"Hong, S.K., H.J. Kim, C.S. Song, I.S. Choi, J.B. Lee, and S.Y. Park. 2012. Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice. International Immunopharmacology 13: 23\u201327.","journal-title":"International Immunopharmacology"},{"key":"994_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pharmthera.2009.05.005","volume":"123","author":"L Li","year":"2009","unstructured":"Li, L., A. Hsu, and P.K. Moore. 2009. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases! Pharmacology & Therapeutics 123: 386\u2013400.","journal-title":"Pharmacology & Therapeutics"},{"key":"994_CR44","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1073\/pnas.0510996103","volume":"103","author":"J Schreiber","year":"2006","unstructured":"Schreiber, J., R.G. Jenner, H.L. Murray, G.K. Gerber, D.K. Gifford, and R.A. Young. 2006. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 103: 5899\u20135904.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"994_CR45","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1567-5769(02)00058-9","volume":"2","author":"T Wang","year":"2002","unstructured":"Wang, T., X. Zhang, and J.J. Li. 2002. The role of NF-\u03baB in the regulation of cell stress responses. International Immunopharmacology 2: 1509\u20131520.","journal-title":"International Immunopharmacology"},{"key":"994_CR46","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/physrev.00028.2011","volume":"92","author":"JM Kyriakis","year":"2012","unstructured":"Kyriakis, J.M., and J. Avruch. 2012. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiological Reviews 92: 689\u2013737.","journal-title":"Physiological Reviews"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00994-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-019-00994-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00994-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T19:35:14Z","timestamp":1585683314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-019-00994-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1007\/s10753-019-00994-3","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"2 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}